Skip to main content
. 2021 Nov 17;12:742834. doi: 10.3389/fimmu.2021.742834

Table 4.

The proportion (%) of CD4+ lymphocytes in patients with 18q del, patients with T1D (control group), and 28 healthy controls.

18q del (n = 24) T1D (n = 24) Control (n = 28) p-value in ANOVA
T subsets (%)
CD4+
Median 21.82 54.27 40.50
Mean (min–max) 22.87 (4.42–50.59) 56.94 (43.93–78.9) 40.94 (24.07–56.12) <0.0001
SD 11.42 10.47 7.61
Tnaive
Median 62.49 63.02 53.85
Mean (min–max) 58.54 (28.31–82.55) 62.08 (19.88–82.93) 50.08 (11.67–58.68) <0.0003
SD 14.66 15.52 16.68
Tcm
Median 23.82 24.29 30.32
Mean (min–max) 25.37 (12.35–37.6) 22.91 (6.65–39.18) 32.91 (17.00–58.68) <0.0001
SD 7.32 9.25 11.15
Tem
Median 9.8 7.08 13.96
Mean (min–max) 9.8 (2.08–28.4) 8.091 (2.87–18.71) 32.91 (17.00–58.68) <0.0001
SD 6.97 4.261 11.15
Treg FOXP3+
Median 2.2 4.88 6.00
Mean (min–max) 2.91 (0.5–8.96) 5.26 (2.35–9.24) 5.95 (2.30–9.40) <0.0001
SD 2.03 1.73 1.99
Treg FOXP3+Helios+
Median 6.41 73.59 78.54
Mean (min–max) 9.17 (2.86–31.89) 75.27 (36.92–95.39) 78.65 (56.66–97.11) <0.0001
SD 7.616 12.73 11.09